genomic technology News
-
Hello world!
inDNA Research Labs is an early stage genomics-driven personalized healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by empowering physicians to utilize a patient’s genomic profile to improve clinical decisions thus transforming patient care. This website is ...
-
ID Genomics’ technology covered by GeekWire
The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it is so they can give the most effective treatment. But growing bacteria in a lab to identify it takes hours to days. That means doctors have to make their best guess, and because there are dozens of possible strains, they guess wrong up to a third of the time. Seattle biotech startup ID ...
-
Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will provide a corporate presentation at the H.C. Wainwright BIOCONNECT Virtual Conference on Monday, January 10th at 7:00 a.m. Eastern Time. The virtual session may be accessed on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The ...
-
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Jefferies Healthcare Conference Date: Thursday, June 9 at 9:00 a.m. Eastern Time Guggenheim I&I Spotlight Series – Treg-based Therapies Date: Tuesday, July 12 at 2:45 p.m. Eastern Time Access links for presentations, ...
-
Population Diagnostics Announces Corporate Name Change to Population Bio to Signify its Broad Precision Medicine Focus
Melville, NY, (December 21, 2016) Population Diagnostics – a global leader in gene discovery for complex disease announced today that it is changing its corporate name to Population Bio. The name change reflects the company's broader commitment to precision medicine and its expertise in driving the innovations needed to shape the future of drug development and predictive diagnostics. The ...
-
Eagle Genomics Appoints Tarun Rishi as New VP Engineering to Further Scale Platform Capabilities
Strategic tech leadership appointment comes as industries race to innovate as part of the Bio Revolution - driving demand for advanced, AI-augmented knowledge discovery capabilities Tarun’s impressive career of >25 years includes tech leadership positions in the financial and security sectors Eagle Genomics, the platform business pioneering the application of network science to ...
-
PercayAI and Saint Louis University Partner to Accelerate AI Adoption across Biomedical Sciences Research
Biotech firm PercayAI and Saint Louis University (SLU) announced a partnership today to provide SLU researchers with access to PercayAI’s augmented intelligence (AI) drug discovery platform. One of the primary components of the PercayAI platform is CompBio™, software co-developed with the Genome Technology Access Center at the McDonnell Genome Institute (GTAC@MGI) at Washington ...
By PercayAI
-
Mila Announces Collaboration with Leading AI Therapeutics Company Deep Genomics
Mila, the Quebec Artificial Intelligence Institute, today announced the start of a partnership with Deep Genomics, a leading company in therapeutic artificial intelligence treatments. This collaboration will allow the company to join Mila's community and to take advantage of the recruitment activities offered by the research institute. Deep Genomics uses AI and machine learning to program and ...
-
Roswell Biotechnologies Unveils First Molecular Electronics Chip to Digitize Biology
Roswell Biotechnologies, Inc., the molecular electronics company, announced today the introduction of the first molecular electronics chip and the Roswell Molecular Electronics (ME) Platform for biosensing applications. The company unveiled the technology along with an early development partnership program at its inaugural Molecular Electronics Day in San Diego, which also marked the 50th ...
-
Agilent Technologies SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems
Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry's leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve the ...
-
CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics recently launched various types of genotyping analysis services, including analysis of data generated by different ...
By CD Genomics
-
Agilent Technologies Presents 2015 Early Career Professor Award to Dr. Mitchell Guttman of Caltech
Agilent Technologies Inc. (NYSE: A) today named Dr. Mitchell Guttman the winner of its 2015 Early Career Professor Award. The award, now in its seventh year, recognizes one early career professor for his or her exceptional, original research contributions and outstanding potential for future research. Dr. Guttman was selected from a global pool of professors contributing to the understanding and ...
-
Agilent Technologies releases new cytogenetics software, providing complete solution for researchers
Agilent Technologies Inc. (NYSE: A) today introduced Agilent CytoGenomics 1.5 software. This analytical tool gives researchers the ability to streamline their analysis by querying the in-house CytoGenomic database and external databases. The software is designed for easy data interpretation and simple report generation. Agilent provides the most accepted microarray platform for cytogenetics, and ...
-
Agilent Technologies Introduces OneSeq to Streamline Cytogenetic Research
Agilent Technologies Inc. (NYSE: A) today introduced OneSeq, the industry's first all-in-one target enrichment product for next-generation sequencing. OneSeq is designed to detect and analyze copy number variations, loss of heterozygosity, and mutations in a single reaction for use in constitutional disease research. Agilent is showcasing the new product at the annual Advances in Genome Biology ...
-
Agilent Technologies Joins Forces with Baylor College of Medicine to Provide Customized CGH Microarrays for Cancer, Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable ...
-
ChunLab purchases Irys System for whole genome mapping
BioNano Signs Two New Distributors For The Asia-Pacific Region And Announces First Irys System Placement In Korea To ChunLab Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact ...
-
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie (NYSE: ABBV) and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today that they have entered into a collaboration and license agreement for the research and development of chimeric antigen receptor (CAR)-T cell therapeutics. Although allogeneic, “off-the-shelf” CAR-T cell therapies have shown early promise in some ...
-
CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research
CD Genomics, a prominent leader in the genomics and transcriptomics arena, proudly unveils its latest innovation, the Degradome Sequencing service. This technology promises to revolutionize the field of transcriptomics research, offering researchers an unprecedented window into RNA degradation patterns and elevating our comprehension of gene regulation and expression. RNA degradation is a ...
By CD Genomics
-
CD Genomics Redefines Genomic Research with Full-Length Transcripts Sequencing (Iso-Seq)
CD Genomics, a leading provider of genomic solutions, has announced a groundbreaking development in genomic research with the introduction of their Full-Length Transcripts Sequencing (Iso-Seq) technology. This innovative advancement promises to revolutionize the field, providing researchers in the life sciences with an unprecedented opportunity to gain comprehensive insights into the complexity ...
By CD Genomics
-
Peer-Reviewed Clinical Study Shows ID Genomics’ Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care
SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum antibiotics, which could ultimately improve patient outcomes and slow the spread of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you